Research On Financial Risk Identification And Control Of Blue Sail Medical’s Transnational Merger And Acquisition Of Biosensors International

This thesis selects the case of Blue Sail Medical’s cross-border merger and acquisition of Biosensors International to study the identification and control of its financial risks in cross-border mergers and acquisitions.First of all,this thesis defines the relevant concepts of cross-border mergers and acquisitions,financial risks and financial risks of cross-border mergers and acquisitions,and expounds the theory of synergy,international production compromise theory and information asymmetry theory.The status of the company,the process of mergers and acquisitions and the reasons for mergers and acquisitions are introduced;then the identification and control of its financial risks are analyzed from the aspects of target selection,financing,payment,exchange rate and integration,etc.,focusing on the use of financial indicators method and Z The value model quantitatively analyzes its financial risk,and through calculation,it is found that its Z value and its various sub-items have dropped significantly after the merger..After mergers and acquisitions,its profitability,solvency and operating capabilities have declined to varying degrees,indicating that its financial risks have increased.The research suggests that enterprises should prudently choose investment targets when conducting cross-border mergers and acquisitions,and select financing methods that suit themselves.Exchange rate changes should be used by the acquirer to resolve the resulting financial risks by using financial instruments and signing relevant agreements.For the post-merger integration,the acquirer should coordinate human resources,management resources and financial resources to reduce the impact on the financial situation of the company.